Liver transplantation for progressive familial intrahepatic cholestasis: Clinical and histopathological findings, outcome and impact on growth

:  In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pediatric transplantation Ročník 11; číslo 6; s. 634 - 640
Hlavní autoři: Aydogdu, Sema, Cakir, Murat, Arikan, C., Tumgor, Gokhan, Yuksekkaya, Hasan Ali, Yilmaz, Funda, Kilic, Murat
Médium: Journal Article
Jazyk:angličtina
Vydáno: Oxford, UK Blackwell Publishing Ltd 01.09.2007
Blackwell
Témata:
ISSN:1397-3142, 1399-3046
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract :  In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.
AbstractList In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.
In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score<2), and four patients had weight SD score<2. Liver transplantation were performed at the age of 43.2+/-27 months (range 9 to 96 months), 6.5+/-3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score<2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r=0.588 (p=0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.
:  In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.
In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive familial intrahepatic cholestasis. We also analyze outcome and impact of liver transplantation on growth and bone mineral content. Most of the patients were presented with jaundice mainly beginning within the first six months. At the time of initial admission; eight patients had short stature (height SD score <2), and four patients had weight SD score <2. Liver transplantation were performed at the age of 43.2 ± 27 months (range 9 to 96 mfonths), 6.5 ± 3.5 months later after the first admission. Infection, surgical complications and osmotic diarrhea associated with severe metabolic acidosis were noted in 41.4%, 16.6% and 33.3%, respectively. One patient developed posttransplant lymphoproliferative disorder. Overall; 1 year graft and patient survival was 69.2% and 75%, respectively. At the end of the 1 st year only 2 patients had height SD score <2. Linear regression of height gain against increase in total body BMD measured at the time of transplantation and 1 year after liver transplantation gave a coefficient r  = 0.588 (p = 0.074). No correlation was found between the height gain and age and PELD score at time of transplantation, and no difference was noted between the sexes and donor type. Liver transplantation is effective treatment modality with good outcome and little morbidity, and increases the growth acceleration in patients with PFIC associated with cirrhosis.
Author Arikan, C.
Cakir, Murat
Yuksekkaya, Hasan Ali
Tumgor, Gokhan
Yilmaz, Funda
Kilic, Murat
Aydogdu, Sema
Author_xml – sequence: 1
  givenname: Sema
  surname: Aydogdu
  fullname: Aydogdu, Sema
  organization: Department of Pediatric Gastroenterology Hepatology and Nutrition
– sequence: 2
  givenname: Murat
  surname: Cakir
  fullname: Cakir, Murat
  organization: Department of Pediatric Gastroenterology Hepatology and Nutrition
– sequence: 3
  givenname: C.
  surname: Arikan
  fullname: Arikan, C.
  organization: Department of Pediatric Gastroenterology Hepatology and Nutrition
– sequence: 4
  givenname: Gokhan
  surname: Tumgor
  fullname: Tumgor, Gokhan
  organization: Department of Pediatric Gastroenterology Hepatology and Nutrition
– sequence: 5
  givenname: Hasan Ali
  surname: Yuksekkaya
  fullname: Yuksekkaya, Hasan Ali
  organization: Department of Pediatric Gastroenterology Hepatology and Nutrition
– sequence: 6
  givenname: Funda
  surname: Yilmaz
  fullname: Yilmaz, Funda
  organization: Department of Pathology
– sequence: 7
  givenname: Murat
  surname: Kilic
  fullname: Kilic, Murat
  organization: Organ Research and Transplantation Center, Ege University, Faculty of Medicine, Bornova, İzmir, Turkiye
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18964890$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/17663686$$D View this record in MEDLINE/PubMed
BookMark eNqNkduO0zAQhi20iD3AKyDfwBUJdpwjEkhQ7RakChBaDnfWxHFal8QOdsp2X2KfmWlTisQNWLI8sr9_rPn_c3JindWEUM5ijuv5OuaiqiLB0jxOGCti3EkSb--Rs-PDyb4uIsHT5JSch7BmjOdpmT4gp7zIc5GX-Rm5W5if2tPRgw1DB3aE0ThLW-fp4N3S6xAQoC30pjPQUWMRXekBMUXVynU6jBBMeEFnnbFGIQK2oSsTRocQAm65v22NbYxdhmfUbUbler3nTD-AGin-uPTuZlw9JPdb6IJ-dDgvyOery-vZ22jxYf5u9noRqYzxJBKgdQZZwtIUKlUzVXIoeNtAXbZVJkCkWZJx0RQC32qWAPCs4XXK8zIVeC8uyNOpLw75Y4MzyN4EpTt0QLtNkHnJWVVUOYKPD-Cm7nUjB2968Lfyt4MIPDkAEHDOFo1UJvzhygo9rxhyryZOeReC161UZjIbDTWd5EzuopVruUtQ7hKUu2jlPlq5xQblXw2Of_xb-nKS3phO3_63Tn68vP6EFeqjSY-p6u1RD_67zAtRZPLr-7mcL7JEfPsi5BvxC1nGzR4
CitedBy_id crossref_primary_10_1007_s11894_009_0013_7
crossref_primary_10_3390_bioengineering9080392
crossref_primary_10_4285_kjt_21_0007
crossref_primary_10_1016_j_jceh_2013_10_005
crossref_primary_10_1002_lt_21470
crossref_primary_10_1111_j_1600_6143_2010_03397_x
crossref_primary_10_1080_14728214_2024_2336986
crossref_primary_10_5500_wjt_v6_i2_278
crossref_primary_10_1111_j_1399_3046_2011_01514_x
crossref_primary_10_1016_j_transproceed_2016_02_067
crossref_primary_10_1002_lt_21686
crossref_primary_10_1002_lt_21520
crossref_primary_10_1002_hep4_1149
crossref_primary_10_1016_j_jpedsurg_2011_08_010
crossref_primary_10_1097_MPG_0000000000002118
crossref_primary_10_1002_hep_31787
crossref_primary_10_1016_j_jhep_2009_11_012
crossref_primary_10_1016_j_transproceed_2017_03_035
crossref_primary_10_1016_j_anpedi_2009_08_005
crossref_primary_10_1111_ajt_15354
crossref_primary_10_3390_antiox11050961
crossref_primary_10_1007_s12098_011_0516_8
crossref_primary_10_1002_hep_28311
crossref_primary_10_1097_MPG_0000000000001815
crossref_primary_10_1111_petr_12741
crossref_primary_10_1016_j_transproceed_2017_06_011
crossref_primary_10_1007_s12016_014_8457_4
crossref_primary_10_1111_hepr_13222
crossref_primary_10_3390_jcm11164684
crossref_primary_10_3390_medicina57080854
crossref_primary_10_1016_j_jpedsurg_2016_11_021
crossref_primary_10_4254_wjh_v14_i1_98
crossref_primary_10_1186_s13023_021_01884_4
crossref_primary_10_1016_j_ymgme_2010_02_008
crossref_primary_10_1111_petr_14108
crossref_primary_10_14701_ahbps_21_114
crossref_primary_10_5812_ijp_117380
crossref_primary_10_1016_j_jceh_2016_05_003
crossref_primary_10_4132_jptm_2019_05_03
crossref_primary_10_1007_s10620_014_3220_5
Cites_doi 10.1053/jlts.2002.34384
10.1055/s-2001-19038
10.1097/00005176-200410000-00018
10.1002/hep.510250303
10.1111/j.1440-1746.2005.03743.x
10.1097/00005176-199705000-00011
10.1111/j.1399-3046.2004.00240.x
10.1002/hep.21287
10.1080/02724936.1995.11747792
10.1002/hep.510260121
10.1001/archpedi.1969.02100030114014
10.1016/S0022-3468(98)90435-3
10.1203/00006450-199001000-00006
10.1016/S0168-8278(03)00286-1
10.1055/s-2001-19034
10.1097/00005176-199402000-00002
10.1046/j.1440-1746.2002.02717.x
10.1034/j.1478-3231.2003.00856.x
10.1034/j.1399-3046.1999.00046.x
10.1002/hep.1840090216
ContentType Journal Article
Copyright 2007 INIST-CNRS
Copyright_xml – notice: 2007 INIST-CNRS
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1399-3046.2007.00722.x
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1399-3046
EndPage 640
ExternalDocumentID 17663686
18964890
10_1111_j_1399_3046_2007_00722_x
PETR722
ark_67375_WNG_GL523XV3_B
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OC
29O
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHQN
AAIPD
AAKAS
AAMMB
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEFGJ
AEIGN
AEIMD
AENEX
AEUYR
AEYWJ
AFBPY
AFEBI
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BSCLL
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WVDHM
WXI
WXSBR
XG1
YFH
ZZTAW
~IA
~WT
AAHHS
ACCFJ
AEEZP
AEQDE
AEUQT
AFPWT
AIWBW
AJBDE
ALUQN
WRC
AAYXX
CITATION
O8X
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c5012-3aee5a52044a9cb0c81a71fdab8f953a3452513d73b0cb02aa15d1b41684313d3
IEDL.DBID DRFUL
ISICitedReferencesCount 49
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000249004000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1397-3142
IngestDate Sun Nov 09 12:38:49 EST 2025
Thu Apr 03 07:00:25 EDT 2025
Mon Jul 21 09:13:52 EDT 2025
Sat Nov 29 03:28:50 EST 2025
Tue Nov 18 22:35:01 EST 2025
Wed Jan 22 17:11:56 EST 2025
Tue Nov 11 03:32:29 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Pediatrics
Prognosis
Growth
Hepatic disease
Transplantation
Biliary tract disease
Homotransplantation
Intrahepatic cholostasis
Histopathology
Surgery
Evolution
Graft
Intrahepatic
Somatic growth
Child
Human
Digestive system
Family study
Progressive
Symptomatology
Anatomic pathology
Treatment
Digestive diseases
progressive familial intrahepatic
liver transplantation
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5012-3aee5a52044a9cb0c81a71fdab8f953a3452513d73b0cb02aa15d1b41684313d3
Notes ArticleID:PETR722
istex:8F8C453FE3F7E5D1B78505BA7D90D6A81848CC91
ark:/67375/WNG-GL523XV3-B
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 17663686
PQID 68109796
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_68109796
pubmed_primary_17663686
pascalfrancis_primary_18964890
crossref_citationtrail_10_1111_j_1399_3046_2007_00722_x
crossref_primary_10_1111_j_1399_3046_2007_00722_x
wiley_primary_10_1111_j_1399_3046_2007_00722_x_PETR722
istex_primary_ark_67375_WNG_GL523XV3_B
PublicationCentury 2000
PublicationDate September 2007
PublicationDateYYYYMMDD 2007-09-01
PublicationDate_xml – month: 09
  year: 2007
  text: September 2007
PublicationDecade 2000
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: Oxford
– name: Denmark
PublicationTitle Pediatric transplantation
PublicationTitleAlternate Pediatr Transplant
PublicationYear 2007
Publisher Blackwell Publishing Ltd
Blackwell
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell
References Knısely AS, Strautnıeks SS, Meıer Y, et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 2006: 44: 478-486.
Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000: 95: 3522-3528.
Nagasaka H, Yorifuji T, Kosugiyama K, et al. Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone. J Pediatr Gastroenterol Nutr 2004: 39: 404-409.
Kurbegov AC, Setchell KD, Haas JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003: 125: 1227-1234.
Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 2002: 17: 938-948.
Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997: 25: 519-523.
Van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: A spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001: 21: 535-544.
Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC-1) and Byler syndrome]: Evidence for heterogeneity. Hepatology 1997: 26: 155-164.
Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003: 23: 315-322.
Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res 1990: 27: 26-31.
Egawa H, Yorifuji T, Sumazaki R, et al. Intractable diarrhea after liver transplantation for Byler's disease: Successful treatment with bile adsorptive resin. Liver Transpl 2002: 8: 714-716.
Heubi JE, Hollis BW, Specker B, et al. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989: 9: 258-264.
Shneider BL. Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy. Pediatr Transplant 2004: 8: 609-612.
Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969: 117: 112-124.
Thompson R, Strautnieks S. BSEP: Function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001: 21: 545-550.
Lykavieris P, Van Mil S, Cresteil D, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003: 39: 447-452.
Naveh Y, Bassan L, Rosenthal E, et al. Progressive familial intrahepatic cholestasis among the Arab population in Israel. J Pediatr Gastroenterol Nutr 1997: 24: 548-554.
Kagalwalla AF, Al Amir AR, Khalifa A, et al. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann Trop Paediatr 1995: 15: 321-327.
Wanty C, Joomye R, Van Hoorebeek N, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 2004: 67: 313-319.
Harris MJ, Le Couteur DG, Arias IM. Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters. J Gastroenterol Hepatol 2005: 20: 807-817.
Ismail H, Kalicinski P, Markiewicz M, et al. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion. Pediatr Transplant 1999: 3: 219-224.
Alonso EM, Snover DC, Montag A, et al. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994: 18: 128-133.
Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R, Loret-de-Mola O, Nahmad M, Burnweit CA. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J Pediatr Surg 1998: 33: 220-224.
2002; 17
1990; 27
1995; 15
2004; 39
2006; 44
1997; 26
2004; 8
1997; 25
2004; 67
1989; 9
1997; 24
2002; 8
2000; 95
2005; 20
2003; 39
1999; 3
1994; 18
1969; 117
2003; 125
1998; 33
2003; 23
2001; 21
Melter M (e_1_2_6_21_2) 2000; 95
Kurbegov AC (e_1_2_6_20_2) 2003; 125
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_18_2
Wanty C (e_1_2_6_9_2) 2004; 67
e_1_2_6_19_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_12_2
e_1_2_6_24_2
e_1_2_6_13_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_10_2
e_1_2_6_22_2
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
References_xml – reference: Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. J Gastroenterol Hepatol 2002: 17: 938-948.
– reference: Heubi JE, Hollis BW, Specker B, et al. Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism. Hepatology 1989: 9: 258-264.
– reference: Nagasaka H, Yorifuji T, Kosugiyama K, et al. Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone. J Pediatr Gastroenterol Nutr 2004: 39: 404-409.
– reference: Kagalwalla AF, Al Amir AR, Khalifa A, et al. Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children. Ann Trop Paediatr 1995: 15: 321-327.
– reference: Kurbegov AC, Setchell KD, Haas JE, et al. Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 2003: 125: 1227-1234.
– reference: Egawa H, Yorifuji T, Sumazaki R, et al. Intractable diarrhea after liver transplantation for Byler's disease: Successful treatment with bile adsorptive resin. Liver Transpl 2002: 8: 714-716.
– reference: Wanty C, Joomye R, Van Hoorebeek N, et al. Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy. Acta Gastroenterol Belg 2004: 67: 313-319.
– reference: Heubi JE, Hollis BW, Tsang RC. Bone disease in chronic childhood cholestasis. II. Better absorption of 25-OH vitamin D than vitamin D in extrahepatic biliary atresia. Pediatr Res 1990: 27: 26-31.
– reference: Shneider BL. Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy. Pediatr Transplant 2004: 8: 609-612.
– reference: Thompson R, Strautnieks S. BSEP: Function and role in progressive familial intrahepatic cholestasis. Semin Liver Dis 2001: 21: 545-550.
– reference: Harris MJ, Le Couteur DG, Arias IM. Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters. J Gastroenterol Hepatol 2005: 20: 807-817.
– reference: Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969: 117: 112-124.
– reference: Hollands CM, Rivera-Pedrogo FJ, Gonzalez-Vallina R, Loret-de-Mola O, Nahmad M, Burnweit CA. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritus. J Pediatr Surg 1998: 33: 220-224.
– reference: Knısely AS, Strautnıeks SS, Meıer Y, et al. Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 2006: 44: 478-486.
– reference: Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC-1) and Byler syndrome]: Evidence for heterogeneity. Hepatology 1997: 26: 155-164.
– reference: Jacquemin E, Hermans D, Myara A, et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997: 25: 519-523.
– reference: Naveh Y, Bassan L, Rosenthal E, et al. Progressive familial intrahepatic cholestasis among the Arab population in Israel. J Pediatr Gastroenterol Nutr 1997: 24: 548-554.
– reference: Lykavieris P, Van Mil S, Cresteil D, et al. Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch-up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation. J Hepatol 2003: 39: 447-452.
– reference: Melter M, Rodeck B, Kardorff R, et al. Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients. Am J Gastroenterol 2000: 95: 3522-3528.
– reference: Ismail H, Kalicinski P, Markiewicz M, et al. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion. Pediatr Transplant 1999: 3: 219-224.
– reference: Alonso EM, Snover DC, Montag A, et al. Histologic pathology of the liver in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994: 18: 128-133.
– reference: Van Mil SW, Klomp LW, Bull LN, Houwen RH. FIC1 disease: A spectrum of intrahepatic cholestatic disorders. Semin Liver Dis 2001: 21: 535-544.
– reference: Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 2003: 23: 315-322.
– volume: 20
  start-page: 807
  year: 2005
  end-page: 817
  article-title: Progressive familial intrahepatic cholestasis: Genetic disorders of biliary transporters
  publication-title: J Gastroenterol Hepatol
– volume: 24
  start-page: 548
  year: 1997
  end-page: 554
  article-title: Progressive familial intrahepatic cholestasis among the Arab population in Israel
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 39
  start-page: 447
  year: 2003
  end-page: 452
  article-title: Progressive familial intrahepatic cholestasis type 1 and extrahepatic features: No catch‐up of stature growth, exacerbation of diarrhea, and appearance of liver steatosis after liver transplantation
  publication-title: J Hepatol
– volume: 15
  start-page: 321
  year: 1995
  end-page: 327
  article-title: Progressive familial intrahepatic cholestasis (Byler’s disease) in Arab children
  publication-title: Ann Trop Paediatr
– volume: 27
  start-page: 26
  year: 1990
  end-page: 31
  article-title: Bone disease in chronic childhood cholestasis. II. Better absorption of 25‐OH vitamin D than vitamin D in extrahepatic biliary atresia
  publication-title: Pediatr Res
– volume: 17
  start-page: 938
  year: 2002
  end-page: 948
  article-title: Extrahepatic manifestations of cholestasis
  publication-title: J Gastroenterol Hepatol
– volume: 26
  start-page: 155
  year: 1997
  end-page: 164
  article-title: Genetic and morphological findings in progressive familial intrahepatic cholestasis [Byler disease (PFIC‐1) and Byler syndrome]: Evidence for heterogeneity
  publication-title: Hepatology
– volume: 3
  start-page: 219
  year: 1999
  end-page: 224
  article-title: Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion
  publication-title: Pediatr Transplant
– volume: 39
  start-page: 404
  year: 2004
  end-page: 409
  article-title: Resistance to parathyroid hormone in two patients with familial intrahepatic cholestasis: Possible involvement of the ATP8B1 gene in calcium regulation via parathyroid hormone
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 8
  start-page: 714
  year: 2002
  end-page: 716
  article-title: Intractable diarrhea after liver transplantation for Byler’s disease: Successful treatment with bile adsorptive resin
  publication-title: Liver Transpl
– volume: 44
  start-page: 478
  year: 2006
  end-page: 486
  article-title: Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency
  publication-title: Hepatology
– volume: 67
  start-page: 313
  year: 2004
  end-page: 319
  article-title: Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy
  publication-title: Acta Gastroenterol Belg
– volume: 125
  start-page: 1227
  year: 2003
  end-page: 1234
  publication-title: Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile
– volume: 25
  start-page: 519
  year: 1997
  end-page: 523
  article-title: Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis
  publication-title: Hepatology
– volume: 8
  start-page: 609
  year: 2004
  end-page: 612
  article-title: Progressive intrahepatic cholestasis: Mechanisms, diagnosis and therapy
  publication-title: Pediatr Transplant
– volume: 18
  start-page: 128
  year: 1994
  end-page: 133
  article-title: Histologic pathology of the liver in progressive familial intrahepatic cholestasis
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 21
  start-page: 545
  year: 2001
  end-page: 550
  article-title: BSEP: Function and role in progressive familial intrahepatic cholestasis
  publication-title: Semin Liver Dis
– volume: 23
  start-page: 315
  year: 2003
  end-page: 322
  article-title: Genetic cholestasis, causes and consequences for hepatobiliary transport
  publication-title: Liver Int
– volume: 117
  start-page: 112
  year: 1969
  end-page: 124
  article-title: Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred
  publication-title: Am J Dis Child
– volume: 33
  start-page: 220
  year: 1998
  end-page: 224
  article-title: Ileal exclusion for Byler’s disease: An alternative surgical approach with promising early results for pruritus
  publication-title: J Pediatr Surg
– volume: 21
  start-page: 535
  year: 2001
  end-page: 544
  article-title: FIC1 disease: A spectrum of intrahepatic cholestatic disorders
  publication-title: Semin Liver Dis
– volume: 9
  start-page: 258
  year: 1989
  end-page: 264
  article-title: Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism
  publication-title: Hepatology
– volume: 95
  start-page: 3522
  year: 2000
  end-page: 3528
  publication-title: Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients
– ident: e_1_2_6_16_2
  doi: 10.1053/jlts.2002.34384
– ident: e_1_2_6_23_2
  doi: 10.1055/s-2001-19038
– ident: e_1_2_6_15_2
  doi: 10.1097/00005176-200410000-00018
– ident: e_1_2_6_8_2
  doi: 10.1002/hep.510250303
– volume: 67
  start-page: 313
  year: 2004
  ident: e_1_2_6_9_2
  article-title: Fifteen years single center experience in the management of progressive familial intrahepatic cholestasis of infancy
  publication-title: Acta Gastroenterol Belg
– ident: e_1_2_6_2_2
  doi: 10.1111/j.1440-1746.2005.03743.x
– volume: 95
  start-page: 3522
  year: 2000
  ident: e_1_2_6_21_2
  publication-title: Progressive familial intrahepatic cholestasis: partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients
– volume: 125
  start-page: 1227
  year: 2003
  ident: e_1_2_6_20_2
  publication-title: Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile
– ident: e_1_2_6_14_2
  doi: 10.1097/00005176-199705000-00011
– ident: e_1_2_6_18_2
  doi: 10.1111/j.1399-3046.2004.00240.x
– ident: e_1_2_6_24_2
  doi: 10.1002/hep.21287
– ident: e_1_2_6_10_2
  doi: 10.1080/02724936.1995.11747792
– ident: e_1_2_6_3_2
  doi: 10.1002/hep.510260121
– ident: e_1_2_6_4_2
  doi: 10.1001/archpedi.1969.02100030114014
– ident: e_1_2_6_19_2
  doi: 10.1016/S0022-3468(98)90435-3
– ident: e_1_2_6_13_2
  doi: 10.1203/00006450-199001000-00006
– ident: e_1_2_6_17_2
  doi: 10.1016/S0168-8278(03)00286-1
– ident: e_1_2_6_22_2
  doi: 10.1055/s-2001-19034
– ident: e_1_2_6_11_2
  doi: 10.1097/00005176-199402000-00002
– ident: e_1_2_6_6_2
  doi: 10.1046/j.1440-1746.2002.02717.x
– ident: e_1_2_6_5_2
  doi: 10.1034/j.1478-3231.2003.00856.x
– ident: e_1_2_6_7_2
  doi: 10.1034/j.1399-3046.1999.00046.x
– ident: e_1_2_6_12_2
  doi: 10.1002/hep.1840090216
SSID ssj0016484
Score 2.0264375
Snippet :  In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive...
In this study, we analyze the demographic features, clinical and histopathological findings in patients who underwent liver transplantation for progressive...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 634
SubjectTerms Biological and medical sciences
Bone Density
Child
Child, Preschool
Cholestasis, Intrahepatic - complications
Cholestasis, Intrahepatic - genetics
Cholestasis, Intrahepatic - pathology
Cholestasis, Intrahepatic - surgery
Disease Progression
Female
Gastroenterology. Liver. Pancreas. Abdomen
General aspects
Growth
Humans
Infant
liver transplantation
Liver Transplantation - adverse effects
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Other diseases. Semiology
progressive familial intrahepatic
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Treatment Outcome
Title Liver transplantation for progressive familial intrahepatic cholestasis: Clinical and histopathological findings, outcome and impact on growth
URI https://api.istex.fr/ark:/67375/WNG-GL523XV3-B/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1399-3046.2007.00722.x
https://www.ncbi.nlm.nih.gov/pubmed/17663686
https://www.proquest.com/docview/68109796
Volume 11
WOSCitedRecordID wos000249004000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library
  customDbUrl:
  eissn: 1399-3046
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0016484
  issn: 1397-3142
  databaseCode: DRFUL
  dateStart: 19990101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BghCX8iw1j7AHxAkj2-v1ernxaMohRFXVltxW-3IbETkoTkp_Bb-ZmbWTEtRDhbhEkdYTeyff7I5nZr8h5LXJZWYyncaZqIo4L6yLpXNFXAGgPWxPWoaY7ulIjMflZCIPu_onPAvT8kNsAm5oGWG9RgPXptk2cthcY8zsrZkIRZa9A3-ynwGM8x7pfz4anow2OYUiL9sWtxIjc_lfdT3X_tbWZtVHvV9i8aRuQH9V2_jiOs9029ENO9Xw_v-c4wOy0_mr9EMLsIfklq8fkbtfu4z8Y_JrhIUddBk40me6PchUU3CFaSj9wirbC09DHAWgTqcYTD73WMdtKS69MCPdTJv3tGMonVFdOxpokLFb8nptpiG5Xp81b-l8tYR5-HBde8iTwh3PFvOfy_Mn5GS4f_zpS9z1eIgtT5AvUXvPNc-SPNfSmsSWqRZp5bQpK8mZZph3TZkTDMZMkmmdcpcacCNLcH2YY7ukV89rv0eo5U57WK21M3nOrdTMBhnD4LPkJiJi_Wcq2xGgYx-OmfrjRQjUrVDd2J4TM_OgbnUZkXQj-aMlAbmBzJuAl42AXnzHIjrB1bfxgToY8YxNTpn6GJHBFqCu7lBKgKxMIvJqjTAFto8JHV37-apRyCUnhSwi8rQF3pWsAE-yKGGkCPi68WOrw_3jI_j27F8Fn5N7bfgby_BekN5ysfIvyR17sZw2iwG5LSbloLPM39taN4c
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQi4CX8ZuFweYHxBNBSRwnMW8D1g2RVdPUjb5Zju1sFVU6Nem2v4K_mTsn7Sjaw4R4qSo518TX7-zL3fk7Qt4VsYiKSIV-lJaJHyfa-MKYxC8B0Ba2JyVcTPc0T4fDbDwWR107IDwL0_JDrAJuaBluvUYDx4D0upXD7upjam9JRZhG0UdwKPsxoIr3SP_r8eAkXyUVkjhre9wKDM3FfxX23Ppba7tVHxV_jdWTqgYFlm3ni9tc03VP121Vg8f_dZJPyEbnsdLdFmJPyT1bPSMPDruc_HPyK8fSDto4lvSpao8yVRScYeqKv7DO9tJSF0kBsNMJhpPPLVZya4qLL0xJ1ZP6E-04SqdUVYY6ImTsl7xcnalLr1dn9Qc6WzQwEeuua495Urjj2Xx21Zy_ICeDvdGXA7_r8uBrHiBjorKWKx4FcayELgKdhSoNS6OKrBScKYaZ15CZlMFYEURKhdyEBTiSGTg_zLCXpFfNKrtJqOZGWVivlSnimGuhmHYyBYPPjBceSZf_ptQdBTp24pjKP16FQN0S1Y0NOjE3D-qW1x4JV5IXLQ3IHWTeO8CsBNT8J5bRpVz-GO7L_ZxHbHzK5GePbK8h6uYOmQDMisAjO0uISbB-TOmoys4WtUQ2OZGKxCOvWuTdyKbgSyYZjCQOYHd-bHm0NzqGb6__VXCHPDwYHeYy_zb8vkUetcFwLMp7Q3rNfGHfkvv6spnU8-3OQH8DJbY6jw
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQiiZe-P4IH5sfEE8EJXGcxLwBWwciVNW0jb5Zju1sFVU6NenYX8HfzJ2ddhTtYUK8VJWca-Lr7-zL3fl3hLyuUpFUiYrDJK-zMM20CYUxWVgDoC1sT0q4mO5JmY9GxWQixn07IDwL4_kh1gE3tAy3XqOB23NTb1o57K4hpvZWVIR5krwDh3KQcpGBlQ72DofH5TqpkKWF73ErMDSX_lXYc-1vbexWA1T8JVZPqhYUWPvOF9e5ppuertuqhvf-6yTvk7u9x0o_eIg9ILds85Bsf-tz8o_IrxJLO2jnWNJnyh9laig4w9QVf2Gd7YWlLpICYKdTDCefWazk1hQXX5iSaqfte9pzlM6oagx1RMjYL3m1OlOXXm9O27d0vuxgItZd5495Urjj6WL-szt7TI6H-0efPod9l4dQ8wgZE5W1XPEkSlMldBXpIlZ5XBtVFbXgTDHMvMbM5AzGqihRKuYmrsCRLMD5YYY9IVvNvLHPCNXcKAvrtTJVmnItFNNOpmLwWfAqIPnq35S6p0DHThwz-cerEKhborqxQSfm5kHd8jIg8Vry3NOA3EDmjQPMWkAtfmAZXc7l99GBPCh5wiYnTH4MyM4Goq7uUAjArIgCsruCmATrx5SOaux82UpkkxO5yALy1CPvSjYHXzIrYCRzALvxY8vx_tEhfHv-r4K7ZHu8N5Tll9HXF-SOj4VjTd5LstUtlvYVua0vumm72Ont8zdawjoK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+transplantation+for+progressive+familial+intrahepatic+cholestasis%3A+clinical+and+histopathological+findings%2C+outcome+and+impact+on+growth&rft.jtitle=Pediatric+transplantation&rft.au=Aydogdu%2C+Sema&rft.au=Cakir%2C+Murat&rft.au=Arikan%2C+C&rft.au=Tumgor%2C+Gokhan&rft.date=2007-09-01&rft.issn=1397-3142&rft.volume=11&rft.issue=6&rft.spage=634&rft_id=info:doi/10.1111%2Fj.1399-3046.2007.00722.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1397-3142&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1397-3142&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1397-3142&client=summon